© 2003 by European Society of Cardiology
Treatment of atrial fibrillation by catheter-based procedures
Clinical Electrophysiology Unit, Department of Cardiology, Thoraxcentre, Erasmus Medical Centre P.O. Box 2040, Office D 307, NL-3000 CA Rotterdam, The Netherlands
Manuscript submitted 25 May 2004. Accepted after revision 28 June 2004.
*Tel.: +31 104 63 2699; fax: +31 104 63 2701. E-mail address: l.jordaens{at}erasmusmc.nl
 |
Abstract |
|---|
 Top Abstract IntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
Catheter-based procedures have been developed with a view to reproduce or improve upon the excellent results of the Maze procedure in the treatment of atrial fibrillation (AF). Linear epicardial lesions created using minimally invasive techniques, or endocardial lesions to encircle the pulmonary veins (PV) have been associated with restoration of sinus rhythm in high percentages of carefully selected patients. The tricuspid-caval isthmus interruption procedure for atrial flutter is highly successful and, in patients who have both atrial flutter and fibrillation, prevents the development of AF when combined with antiarrhythmic agents. Modification of atrioventricular (AV) nodal conduction by eliminating the posterior atrial inputs to the AV node is performed to decrease the ventricular rate and alleviate symptoms during AF without the need for permanent pacing, though may be complicated by inadvertent AV block. AV junctional ablation and permanent pacing alleviates cardiac symptoms, improves quality-of-life, and reduces the use of health care resources. Its constraints include the inescapable need for anticoagulation, loss of AV synchrony, and life-long pacemaker-dependency. The variety of methods and results among published studies strongly emphasises the importance of patient selection, and the relative importance of substrate versus trigger. Possible complications of catheter ablation for AF include systemic thromboembolism, PV stenosis, pericardial effusion, cardiac tamponade, and phrenic nerve paralysis. These remain a matter of concern and stimulate research toward the development of less complex procedures.
Key Words: atrial flutter, atrial fibrillation, catheter ablation, pulmonary vein isolation, atrioventricular node ablation
|
Introduction |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
Atrial fibrillation (AF) is the sustained arrhythmia most frequently encountered in clinical practice [1]
. The complex arrangement of atrial myocardial cells and fibres, the relation between atria and systemic and pulmonary veins (PV) [2], and the consequences of ageing, including dilation and fibrosis, explain the ubiquity of AF, which can be considered a disease in itself. The acute manifestations of AF differ from those of its chronic forms, which are now generally classified as paroxysmal, when intermittent and self-terminating, persistent, when requiring an intervention for termination, and permanent, when therapeutic attempts to restore sinus rhythm have been abandoned [3]. This classification combined with clinical information based on echocardiographic measurements, is often the only determinant of eligibility for catheter ablation or other non-pharmacological treatments. It is noteworthy, however, that differences in underlying pathophysiology and disease entity, stage or severity may determine different outcomes after therapeutic attempts with drugs, ablation or devices. |
Non-pharmacological interventions in perspective |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
Antiarrhythmic drugs are often ineffective in the management of AF, and may be the source of severe adverse effects, including, in patients with congestive heart failure, a higher mortality [4]
. Several alternate, non-pharmacological therapies are in various stages of development, and the first attempts to emulate non-invasively the successful surgical Maze procedure can be scrutinised, though evidence-based data are still missing. The latter remain limited by non-uniform study endpoints, a consequence of a disease which primarily affects quality-of-life, and causes cardiac dysfunction only after prolonged periods of time. In addition, the association of lone AF with stroke is weak, such that large patient populations would be needed to examine the effects of invasive interventions on this complication. |
Modifications of substrate and triggers |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
On the basis of mapping studies in animals and humans, Cox developed the Maze operation, which eliminates AF in >90% of selected patients [5]
. The mechanism by which this procedure prevents recurrences of AF was not completely clarified initially, though the barriers to conduction created within the right and left atria limit the amount of myocardium available for the propagation of reentrant wavefronts, thus inhibiting sustained AF [6]. Since the Maze operation isolates the PVs, the subsequent recognition of their role as a source of ectopic activity initiating paroxysms of AF was an important contribution to understanding the mechanisms behind the success of the procedure [7]. The effectiveness of the operation is certainly attributable to a confinement of the triggers of AF, as well as to a block of impulse propagation within the atrial substrate and a modification of the substrate itself. |
Non-surgical treatment alternatives |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
Catheter-based procedures have been developed with a view to reproduce or improve upon these excellent surgical results [8]
. Linear epicardial lesions, aimed at isolating the PVs and created with minimally invasive techniques, have been associated with restoration of sinus rhythm in >90% of patients, up to 1 year [9]. These epicardial techniques are particularly promising since they may have a more direct effect on cardiac innervation [10]. |
Catheter ablation of atrial fibrillation |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
Focal ablation versus segmental pulmonary vein isolation
The treatment of AF entered a new era with the publication of the landmark observations by Haïssaguerre et al. [7]
. The recognition of the role played in the initiation of AF by myocardial extensions within the PV provided a new pathophysiological perspective, changed the therapeutic approach, and explained why surgery was effective. For the first time, one could expect a catheter-based cure of AF, since the presence of ectopic activity was a reliable target to guide ablation. However, this ectopic activity in the PVs is present in no more than one third of patients [11]. Thus, segmental ostial catheter ablation guided by PV potentials may be a better strategy (Fig. 1) than a search for isolated ectopic activity [12]. Even after immediately successful procedures, a high percentage of patients experiences recurrences, and achievable results and endpoints of catheter-based AF ablation have now be redefined, focussing on quality-of-life and reduction of the AF burden. The empirical encircling of the pulmonary venous ostia is a simplified and apparently more effective approach, which, when assisted by detailed mapping (Fig. 2), can be performed expeditiously by experienced operators [13].
|
|
The original focal procedure was associated with up to 8% incidence of PV stenosis, defined as a
50% decrease in luminal diameter, and 16% of patients had a decrease in luminal diameter between 25% and 50% [14]. Since PV stenosis can be life-threatening [15], modifications have been made to the procedure, including ablation encircling the ostia, use of different energy sources, such as cooled tip and cryothermy, and monitoring of radiofrequency heating by intracardiac ultrasound [16–18].
Other foci
Other arrhythmogenic foci which may trigger AF have been found in the superior vena cava, the right and left atria, the coronary sinus, and the ligament of Marshall [19]. Atrioventricular (AV) nodal reentry and accessory pathway-mediated tachycardias represent other triggers. Isolation of the superior vena cava is a simple procedure and has become part of a systematic strategy in some centres.
Linear ablation
With the anatomic and electrical remodelling associated with prolonged AF, the underlying substrate may play a more prominent role. Attempts to emulate the successful Maze operation with left-sided linear ablation have raised concerns regarding the safety and efficacy of the procedure [20]. Ablation confined to the right atrium is safer, though of limited efficacy [21,22]. Its highest reported success rate was in selected patients whose AF tended to organise towards a flutter-like appearance [23]. A difficulty inherent in the creation of linear lesions is the need for uninterrupted contact of the catheter with the endocardium, which may be helped by the use of linear catheters (Fig. 3). Intracardiac echography may be of assistance in these procedures. Because of the limited efficacy of focal ablation, linear lesions are now often combined with segmental or focal isolation [20]. A left atrial isthmus line, from the left lower PV to the mitral valve annulus, is also included in some procedural protocols.
|
|
Ablation of atrial flutter |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
Atrial flutter and AF are closely related arrhythmias, often coexistent in the same patient and evolving from one to the other. Flutter may develop as a consequence of antiarrhythmic drug therapy administered for AF, especially class IC agents or amiodarone. The tricuspid-caval isthmus interruption procedure improves symptoms, and very effectively prevents AF when combined with these antiarrhythmic agents [24]
. Its role as a systematic adjunctive intervention remains to be established [25,26]. |
AV junctional modification and ablation |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
Modification of AV junctional conduction by eliminating the posterior atrial inputs to the AV node is a technically challenging procedure performed to decrease the ventricular rate and alleviate symptoms during AF without the need for permanent pacing, though it may be complicated by inadvertent complete AV block [27]
. This procedure is especially salutary in patients with high ventricular rates and tachycardia-induced decline in ventricular systolic function despite medical therapy [28].
In a meta-analysis of 1181 patients with highly symptomatic AF, AV junctional ablation and permanent pacemaker implantation significantly alleviated cardiac symptoms, improved quality-of-life, and reduced the consumption of health care resources [29]. Complications of AV junctional ablation include those associated with pacemaker implantation, a higher rate of progression from paroxysmal to persistent AF, and ventricular arrhythmias. Worsening of LV function is not uncommon [30]. The 1-year mortality rate after AV junctional ablation and permanent pacemaker implantation is approximately 6%, and the risk of sudden death approximately 2%. Although the relation between sudden death and this procedure remains controversial, it has been suggested that the risk may be reduced by programming the back up pacing rate between 80 and 90 bpm for the first month after ablation [31,32].
The constraints of AV junctional ablation include the inescapable need for anticoagulation, loss of AV synchrony, and life-long pacemaker-dependency. Patients with abnormal diastolic ventricular function, who are most dependent on AV synchrony for preservation of cardiac output, may have persistent symptoms after AV junctional ablation. These considerations should be taken into account before proceeding with this irreversible treatment.
|
Importance of patient selection |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
The variety of methods and results among published studies strongly emphasises the importance of patient selection. In any given patient, the choice among different procedures depends on the relative importance of substrate versus trigger. Clinical characteristics examined before catheterisation, such as age, arrhythmia pattern, left atrial size, and underlying anatomy, play decisive roles with respect to whether or not to proceed with ablation.
|
Procedural complications |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
Possible complications of catheter ablation for AF include systemic thromboembolism, PV stenosis, pericardial effusion, cardiac tamponade, and phrenic nerve paralysis [15,
33,34]. These remain a matter of concern and stimulate research toward the development of less complex procedures. In the meantime, the decision to proceed with AF ablation needs to be weighed carefully. |
Summary |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
There is growing evidence that a wide, circumferential isolation of the ostia of the pulmonary veins is a more effective catheter-based technique for ablation of atrial fibrillation than a focal approach. This does not prevent ablation of documented foci (e.g. superior vena cava, left atrial free wall...). Additional arrhythmias (flutter, but also AV Needal re-entry tachycardia and accessory pathways), potentially triggering atrial fibrillation should be modified whenever possible. Interpretation of success rates depends on the endpoint used.
|
References |
|---|
|
TopAbstractIntroductionNon-pharmacological...Modifications of substrate and...Non-surgical treatment...Catheter ablation of atrial...Ablation of atrial flutterAV junctional modification and...Importance of patient selectionProcedural complicationsSummaryReferences |
|---|
[1] Ryder KM and Benjamin EJ. Epidemiology and significance of atrial fibrillation. Am J Cardiol 1999; 84:9A 131R–138R.[CrossRef][Web of Science][Medline]
[2] Nathan H and Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation 1966; 34: 412–422.
[3] Gallagher MM and Camm AJ. Classification of atrial fibrillation. Pacing Clin Electrophysiol 1997; 20: 1603–1605.[CrossRef][Medline]
[4] Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 1992; 20: 527–532.[Abstract]
[5] Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991; 101: 406–426.[Abstract]
[6] Allessie MA, Konings K, Kirchhof CJ, Wijffels M. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 1996; 77: 10A–23A [abstract].[CrossRef][Medline]
[7] Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659–666.
[8] Haïssaguerre M, Shah DC, Jaïs P, et al. Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. Am J Cardiol 2000; 86:9 Suppl. 1 K9–K19.[CrossRef][Web of Science][Medline]
[9] Kottkamp H, Hindricks G, Autschbach R, et al. Specific linear left atrial lesions in atrial fibrillation: intraoperative radiofrequency ablation using minimally invasive surgical techniques. J Am Coll Cardiol 2002; 40: 475–480.
[10] Schauerte P, Mischke K, Plisiene J, et al. Catheter stimulation of cardiac parasympathetic nerves in humans: a novel approach to the cardiac autonomic nervous system. Circulation 2001; 104: 2430–2435.
[11] De Ponti R, Tritto M, Lanzotti ME, et al. Computerized high-density mapping of the pulmonary veins: new insights into their electrical activation in patients with atrial fibrillation. Europace 2004; 6: 97–108.
[12] Wilber DJ. Linear ablation for atrial fibrillation: have we come full circle? J Am Coll Cardiol 2003; 42: 1283–1285.
[13] Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001; 104: 2539–2544.
[14] Gerstenfeld EP, Guerra P, Sparks PB, Hattori K, Lesh MD. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol 2001; 12: 900–908.[CrossRef][Web of Science][Medline]
[15] Ernst S, Ouyang F, Goya M, et al. Total pulmonary vein occlusion as a consequence of catheter ablation for atrial fibrillation mimicking primary lung disease. J Cardiovasc Electrophysiol 2003; 14: 366–370.[CrossRef][Web of Science][Medline]
[16] Scholten MF, Kimman GJ, Janse PA, Thornton AS, Theuns DAMJ, Jordaens LJ. Electrical isolation of pulmonary veins using cryothermal energy. Neth Heart J 2003; 11: 453–458.
[17] Marrouche NF, Martin DO, Wazni O, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 2003; 107: 2710–2716.
[18] Marrouche NF, Dresing T, Cole C, et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J Am Coll Cardiol 2002; 40: 464–474.
[19] Hwang C, Peter CT, Chen PS. Radiofrequency ablation of accessory pathways guided by the location of the ligament of Marshall. J Cardiovasc Electrophysiol 2003; 14: 616–620.[CrossRef][Web of Science][Medline]
[20] Jaïs P, Shah DC, Haïssaguerre M, et al. Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation. Am J Cardiol 1999; 84: 139R–146R.[CrossRef][Web of Science][Medline]
[21] Jaïs P, Shah DC, Takahashi A, Hocini M, Haïssaguerre M, Clémenty J. Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1998; 21: 2533–2538.[CrossRef][Medline]
[22] Natale A, Leonelli F, Beheiry S, et al. Catheter ablation approach on the right side only for paroxysmal atrial fibrillation therapy: long-term results. Pacing Clin Electrophysiol 2000; 23: 224–233.[CrossRef][Medline]
[23] Wu RC, Berger R, Calkins H. Catheter ablation of atrial flutter and macroreentrant atrial tachycardia. Curr Opin Cardiol 2002; 17: 58–64.[CrossRef][Web of Science][Medline]
[24] Cosio FG, Arribas F, Lopez-Gil M, Gonzalez HD. Radiofrequency ablation of atrial flutter. J Cardiovasc Electrophysiol 1996; 7: 60–70.[Web of Science][Medline]
[25] Huang DT, Monahan KM, Zimetbaum P, Papageorgiou P, Epstein LM, Josephson ME. Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9: 462–469.[Web of Science][Medline]
[26] Reithmann C, Dorwarth U, Dugas M, et al. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter. Eur Heart J 2003; 24: 1264–1272.
[27] Carbucicchio C, Tondo C, Fassini G, et al. Modulation of the atrioventricular node conduction to achieve rate control in patients with atrial fibrillation: long-term results. Pacing Clin Electrophysiol 1999; 22: 442–452.[CrossRef][Medline]
[28] Schoonderwoerd BA, Van Gelder IC, van Veldhuisen DJ, et al. Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol 2001; 12: 1404–1410.[CrossRef][Web of Science][Medline]
[29] Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 2000; 101: 1138–1144.
[30] Szili-Torok T, Kimman GP, Theuns D, Poldermans D, Roelandt JR, Jordaens LJ. Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation. Europace 2002; 4: 61–65.
[31] Jordaens L, Rubbens L, Vertongen P. Sudden death and long-term survival after His bundle ablation. Eur J Cardiac Pacing Electrophysiol 1993; 3: 232–237.
[32] Geelen P, Brugada J, Andries E, Brugada P. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1997; 20: 343–348.[CrossRef][Medline]
[33] Schwab JO, Burkhardt D, Yang A, Schrickel J, Lüderitz B, Lewalter T. ECG signs mimicking acute inferior wall myocardial infarction are associated with elevated myocardial enzymes during isolation of pulmonary vein for focal atrial fibrillation. Europace 2004; 6: 111–115.
[34] Keane D, Mansour M, Singh J. Detection by intracardiac echocardiography of early formation of left atrial thrombus during pulmonary vein ablation. Europace 2004; 6: 109–110.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||